Real-time enrollment status for this hematologic neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:03 PM UTC
| NCT Number | NCT05327023 |
| Recruiting Status | Recruiting |
| Condition | Hematologic Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 430 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 13, 2026: Clinical trial NCT05327023 is currently recruiting participants. This clinical trial study for hematologic neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05327023 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05327023 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.